Pain relief in breast surgery

A randomised control trial comparing the analgesic effects of pectoral nerve block and erector spinae plane block for breast mastectomy surgery.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047142

Enrollment

Registered

2022-11-09

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C500- Malignant neoplasm of nipple and areola Health Condition 2: C508- Malignant neoplasm of overlappingsites of breast Health Condition 3: C502- Malignant neoplasm of upper-innerquadrant of breast

Interventions

Intervention1: Modified Pectoral nerve block: 30 ml of 0.25 % levobupivacaine between Pectoralis Minor and Serratus anterior & Pectoralis major and minor under ultrasound guidance. Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing elective mastectomy surgery

Exclusion criteria

Exclusion criteria: • Patient refusal • Contraindications to regional anaesthesia • Known allergy to local anaesthetics • Bleeding diathesis • Use of any anti-coagulants • Patient on chronic analgesics

Design outcomes

Primary

Measure	Time frame
Total postoperative analgesic consumptionTimepoint: 24hrs after surgery	—

Secondary

Measure	Time frame
Postoperative pain assessment: Numeric pain Rating score (NRS) at rest and movement. Total requirement of rescue analgesia (Fentanyl). Complications, if any, (will be managed subsequently).Timepoint: 30min, 2hrs, 4hrs, 6hrs, 8hrs, 24hrs after surgery	—

Countries

India

Contacts

Public ContactDr Divya Sethi

ESIC-PGIMSR, Basaidarapur, New Delhi

divyasth@gmail.com9891230700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026